title: Route of administration is the prime determinant of IgA and IgG2a responses in the respiratory tract of mice to the cold-adapted live attenuated influenza A donor strain A/Leningrad/134/17/57.
abstract: Serum antibody and antibody secretory cell (ASC) responses to the cold-adapted (CA) live attenuated influenza A donor strain A/Leningrad/134/17/57 in BALB/c mice were determined in the lungs and mediastinal lymph nodes after administration by the intranasal, subcutaneous and intramuscular routes. Both types of response were greatest when an inoculum consisting of 10(6.5) 50% egg infectious doses (EID(50)) was administered twice intranasally at an interval of 3 weeks. Serum responses by the intramuscular route were much higher than by the subcutaneous route but, at doses of 10(6.5-7.5) EID(50), were still lower than that obtained with two doses of an intranasal inoculum of 10(6.5) EID(50). Virus-specific ASC responses for IgA and IgG2a were obtained in the lungs and mediastinal lymph nodes of mice inoculated with 10(6.5) EID(50) by the intranasal route. However, ASC responses after inoculation by either the subcutaneous or intramuscular routes were barely detectable, even at doses as high as 10(7.5) EID(50). These results confirm that intranasal administration of live vaccines induces far higher virus-specific IgA and IgG2a responses in the respiratory tract of mice than can be achieved by parenteral administration and that serum antibody levels induced by parenteral vaccination are unrelated to the respiratory ASC response.
authors.affiliation: Department of Biotechnology and Environmental Biology, RMIT University, P.O. Box 71, Vic. 3083, Bundoora, Australia.
authors.forename: M D
authors.initials: MD
authors.lastname: Wareing
authors.forename: G A
authors.initials: GA
authors.lastname: Tannock
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis / Q000276:immunology; D000921:Antibody-Producing Cells / Q000276:immunology; D004306:Dose-Response Relationship, Immunologic; D018928:Immunity, Mucosal / Q000276:immunology; D007070:Immunoglobulin A / Q000096:biosynthesis*; D007074:Immunoglobulin G / Q000096:biosynthesis*; D009980:Influenza A virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D007273:Injections, Intramuscular; D008168:Lung / Q000276:immunology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D012137:Respiratory System / Q000276:immunology*; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007252:Influenza Vaccines; D014613:Vaccines, Attenuated